Matthias Philipp Lichy, M.D.1,4; David Schilling2, M.D; Claus H. von Weyhern3, M.D.;
Arnulf Stenzl2, M.D.; Matthias Roehtke, M.D.1; Ralph Strecker, Ph.D.4;
Wilhelm Horger4; Berthold Kiefer, Ph.D.4; Claus D. Claussen, M.D.1;
Heinz-Peter Schlemmer, M.D., Ph.D.1
1 University Hospital Tübingen, Department of Diagnostic and Interventional Radiology, Tübingen, Germany
2 University Hospital Tübingen, Department of Urology, Tübingen, Germany
3 University Hospital Tübingen, Department of Pathology, Tübingen, Germany
4 Siemens Healthcare Sector, Erlangen, Germany
The potential of state-of-the-art MRI at 3T without endorectal coil is presented in this case report article. In both shown cases, MRI was able to improve therapy planning and the surgical outcome clearly.
Karl Engelhard, M.D.
Diagnostic Radiology, Martha-Maria Hospital Nuernberg, Nuernberg, Germany
This article examines two important clinical cases for a better understanding of potential benefits, but also limitations, of MRI-guided prostate biopsies. All examinations were performed on a 1.5T system (MAGNETOM® Symphony, Siemens Healthcare, Erlangen, Germany).
Sarah Foster, M.D.; Nick Ferris, M.D.
Department of Diagnostic Radiology, Peter MacCallum Cancer Center, Melbourne, Australia
The patient presented with a rising PSA following brachytherapy for stage T2a N0 M0 Gleason 6 prostate cancer. We scanned the patient using the Siemens 3T MAGNETOM® Trio.
Farhood Saremi, M.D.1; Helmuth Schultze-Haakh, Ph.D.2
1Professor of Radiology and Medicine, University of California, Irvine (UCI), USA
2Siemens Medical Solutions USA, Cypress, CA, USA
In this review, we describe our experience in using DWI for the characterization of genitourinary tract lesions as done on our MAGNETOM® Trio, A Tim® System with the Body Matrix coils.
Re, Thomas Joseph, M.D., MSEE1; Klauss, Miriam, M.D.2; Lemke, Andreas, MSc3, 4;
Laun, Frederik, Ph.D.4; Simon, Dirk, MSc1; Delorme, Stefan, M.D.1; Stieltjes, Bram, M.D.1
1German Cancer Research Center (DKFZ), Department of Radiology – E 010, Heidelberg, Germany
2Department of Diagnostic Radiology, University of Heidelberg, Heidelberg, Germany
3Department of Computer Assisted Clinical Medicine, University of Heidelberg, Mannheim, Faculty of Medicine, Mannheim, Germany
4German Cancer Research Center (DKFZ), Department of Physics in Radiology – E 020, Heidelberg, Germany
Contrast-enhanced magnetic resonance (MR) and computed tomography (CT) imaging are currently the standard imaging modalities for pancreatic lesions. Diffusion-weighted imaging (DWI) could prove a non-invasive alternative, since recent advances in scanner technologies, fast pulse sequences and parallel imaging have permitted its use in the abdomen where organ motion and tissue inhomogeneity have long prevented robust diffusion measurements.
_____________________________
*WIP - Work in progress. This information about this product is preliminary. The product is under development and not commercially available in the U.S., and its future availability cannot be ensured.